Abstract
Mushrooms have extensively been used not only as a dietary intake but also for the treatment of various central nervous system (CNS) and peripheral nervous system (PNS) disorders. At its early stages, accumulated evidence has suggested that culinary-medicinal mushrooms may play a significant role in the prevention of many age-associated neurodegenerative disorders, such as Alzheimer’s and Parkinson’s diseases. Therefore, further research and efforts have been devoted to a search for more mushroom species that may improve memory and cognitive functions and, in addition, prevent the progression of dementia and neurodegeneration. Such mushrooms include Hericium erinaceus, Ganoderma lucidum, Lignosus rhinocerotis, Pleurotus giganteus, Sarcodon scabrosus, Antrodia camphorata, Paxillus panuoides, Mycoleptodonoides aitchisonii, and several other species. This review focuses on the various abovementioned neuroprotective, culinary-medicinal mushrooms and the bioactive secondary metabolites isolated from them. The mushrooms’ extracts from basidiocarps/mycelia or isolated compounds have been known to decrease neurotoxicity through various neuroprotective molecular mechanisms such as anti-acetylcholinesterase activity, neurite outgrowth stimulation (neuritogenic), and nerve growth factor (NGF) synthesis (neurotrophic), enhancing mitochondrial functions and reducing endoplasmic reticulum (ER) stress, in addition to antioxidant and anti-inflammatory effects. Therefore, mushrooms can be considered as useful therapeutic agents in the prevention, management, and/or treatment of neurodegenerative diseases.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AchE:
-
Acetylcholinesterase
- AD:
-
Alzheimer’s disease
- ɑ-KGDH:
-
ɑ-Ketoglutarate dehydrogenase
- ALS:
-
Amyotrophic lateral sclerosis
- Aβ :
-
Amyloid-β
- BBB:
-
Blood-brain barrier
- Ca2+ :
-
Calcium
- CNS:
-
Central nervous system
- DNA:
-
Deoxyribonucleic acid
- EGL:
-
Ethanol extract of Ganoderma lucidum
- ER:
-
Endoplasmic reticulum
- HD:
-
Huntington’s disease
- HO-1:
-
Heme oxygenase-1
- Hsp70:
-
Heat Shock Protein 70
- ICV:
-
Intracerebroventricular
- IL-1β:
-
Interleukin 1β
- LPE:
-
Lysophosphatidylethanolamine
- LPS:
-
Lipopolysaccharide
- LXA4:
-
Lipoxin A4
- NF-κB:
-
Nuclear factor-kappa B
- NGF:
-
Nerve growth factor
- NO:
-
Nitric oxide
- PD:
-
Parkinson’s disease
- PDH:
-
Pyruvate dehydrogenase
- PGE2:
-
Prostaglandin E2
- PNS:
-
Peripheral nervous system
- ROS:
-
Reactive oxygen species
- SDH:
-
Succinate dehydrogenase
- TLR:
-
Toll-like receptor
- TNF-ɑ:
-
Tumor necrosis factor-alpha
- TRX:
-
Thioredoxin
References
Ajith TA, Sudheesh NP, Roshny D, Abishek G, Janardhanan KK (2009) Effect of Ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats. Exp Gerontol 44:219–223. https://doi.org/10.1016/J.EXGER.2008.11.002
Ao ZH, Xu ZH, Lu ZM, Xu HY, Zhang XM, Dou WF (2009) Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases. J Ethnopharmacol 121:194–212. https://doi.org/10.1016/j.jep.2008.10.039
Badham ER (1984) Ethnobotany of psilocybin mushrooms, especially Psilocybe cubensis. J Ethnopharmacol 10:249–254. https://doi.org/10.1016/0378-8741(84)90007-2
Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3:205–214. https://doi.org/10.1038/nrd1330
Baskaran A, Chua KH, Sabaratnam V, Ravishankar Ram M, Kuppusamy UR (2017) Pleurotus giganteus (Berk. Karun & Hyde), the giant oyster mushroom inhibits NO production in LPS/H2O2 stimulated RAW 264.7 cells via STAT 3 and COX-2 pathways. BMC Complement Altern Med 17:40. https://doi.org/10.1186/s12906-016-1546-6
Benjamin C (1979) Persistent psychiatric symptoms after eating psilocybin mushrooms. Br Med J 1:1319–1320
Chia Wei P (2015) Neurite outgrowth stimulatory activity of an edible mushroom Pleurotus giganteus in differentiating neuroblastoma-2a cells. Thesis, University of Malaya, Kuala Lumpur
Chien SC, Chen ML, Kuo HT, Tsai YC, Lin BF, Kuo YH (2008) Anti-inflammatory activities of new succinic and maleic derivatives from the fruiting body of Antrodia camphorata. J Agric Food Chem 56:7017–7022. https://doi.org/10.1021/jf801171x
Choi D, Lee JH, Kim YS, Na M-S, Choi OY, Lee HD, Lee MK, Cha WS (2011) A study of mycelial growth and exopolysaccharide production from a submerged culture of Mycoleptodonoides aitchisonii in an air-lift bioreactor. Korean J Chem Eng 28:1427–1432. https://doi.org/10.1007/s11814-011-0109-2
Choi JH, Suzuki T, Okumura H, Noguchi K, Kondo M, Nagai K, Hirai H, Kawagishi H (2014) Endoplasmic reticulum stress suppressive compounds from the edible mushroom Mycoleptodonoides aitchisonii. J Nat Prod 77:1729–1733. https://doi.org/10.1021/np500075m
Choi MH, Wu Y, Oh DS, Kim SK, Shin HJ (2016) Antioxidant and antidiabetic activities of mycelial and fruit-body extracts from Mycoleptodonoides aitchisonii. Biotechnol Bioprocess Eng 21:355–363. https://doi.org/10.1007/s12257-016-0235-0
Eik LF, Naidu M, David P, Wong KH, Tan YS, Sabaratnam V (2012) Lignosus rhinocerus (Cooke) Ryvarden: a medicinal mushroom that stimulates neurite outgrowth in PC-12 cells. Evid Based Complement Alternat Med 2012:320308. https://doi.org/10.1155/2012/320308
Geethangili M, Tzeng YM (2011) Review of pharmacological effects of Antrodia camphorata and its bioactive compounds. Evid Based Complement Alternat Med 2011:212641. https://doi.org/10.1093/ecam/nep108
Geissler T, Brandt W, Porzel A, Schlenzig D, Kehlen A, Wessjohann L, Arnold N (2010) Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus. Bioorg Med Chem 18:2173–2177. https://doi.org/10.1016/J.BMC.2010.01.074
Giridharan VV, Thandavarayan RA, Konishi T (2011) Amelioration of scopolamine induced cognitive dysfunction and oxidative stress by Inonotus obliquus– a medicinal mushroom. Food Funct 2:320. https://doi.org/10.1039/c1fo10037h
Hsiao G, Shen MY, Lin KH, Lan MH, Wu LY, Chou DS, Lin CH, Su CH, Sheu JR (2003) Antioxidative and hepatoprotective effects of Antrodia camphorata extract. J Agric Food Chem. https://doi.org/10.1021/JF021159T
Huang NK, Cheng JJ, Lai WL, Lu MK (2005) Antrodia camphorata prevents rat pheochromocytoma cells from serum deprivation-induced apoptosis. FEMS Microbiol Lett 244:213–219. https://doi.org/10.1016/j.femsle.2005.01.048
Jo WS, Hossain MA, Park SC (2014) Toxicological profiles of poisonous, edible, and medicinal mushrooms. Mycobiology 42:215–220. https://doi.org/10.5941/MYCO.2014.42.3.215
Journal O, Xu T, Beelman RB (2015) The bioactive compounds in medicinal mushrooms have potential protective effects against neurodegenerative diseases. Adv Food Technol Nutr Sci 1:62–65. https://doi.org/10.17140/AFTNSOJ-1-110
Kawagishi H, Shimada A, Shirai R, Okamoto K, Ojima F, Sakamoto H, Ishiguro Y, Furukawa S (1994) Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceus. Tetrahedron Lett 35:1569–1572. https://doi.org/10.1016/S0040-4039(00)76760-8
Khatun K, Mahtab H, Khanam PA, Sayeed MA, Khan KA (2007) Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects. Mymensingh Med J 16:94–99
Kim EK, Lee SJ, Hwang JW, Kim CG, Choi DK, Lim BO, Kang H, Moon SH, Jeon BT, Park PJ (2011) In Vitro investigation on antioxidative effect of Inonotus obliquus extracts against oxidative stress on PC12 cells. J Korean Soc Appl Biol Chem 54:112–117. https://doi.org/10.3839/jksabc.2011.016
Lee IK, Yun BS, Han G, Cho DH, Kim YH, Yoo ID (2002) Dictyoquinazols A, B, and C, new neuroprotective compounds from the mushroom Dictyophora indusiata. J Nat Prod 65:1769–1772. https://doi.org/10.1021/np020163w
Lee IK, Yun BS, Kim JP, Ryoo IJ, Kim YH, Yoo ID (2003) Neuroprotective activity of p-terphenyl leucomentins from the mushroom Paxillus panuoides. Biosci Biotechnol Biochem 67:1813–1816. https://doi.org/10.1271/bbb.67.1813
Lee I, Ahn B, Choi J, Hattori M, Min B, Bae K (2011) Selective cholinesterase inhibition by lanostane triterpenes from fruiting bodies of Ganoderma lucidum. Bioorg Med Chem Lett 21:6603–6607. https://doi.org/10.1016/J.BMCL.2011.04.042
Lima ADL, Costa Fortes R, Carvalho Garbi Novaes MR, Percário S (2012) Poisonous mushrooms: a review of the most common intoxications. Nutr Hosp 27:402–408. https://doi.org/10.1590/S0212-16112012000200009
Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787–795. https://doi.org/10.1038/nature05292
Lin JM, Lin CC, Chen MF, Ujiie T, Takada A (1995) Radical scavenger and antihepatotoxic activity of Ganoderma formosanum, Ganoderma lucidum and Ganoderma neo-japonicum. J Ethnopharmacol 47:33–41
Ling Sing Seow S, Naidu M, David P, Wong KH, Sabaratnam V (2013) Potentiation of neuritogenic activity of medicinal mushrooms in rat pheochromocytoma cells. BMC Complement Altern Med 13:157. https://doi.org/10.1186/1472-6882-13-157
Mcdonald A (1980) Mushrooms and madness: hallucinogenic mushrooms and some psychopharmacological implications. Can J Psychiatr 25:586–594. https://doi.org/10.1177/070674378002500709
McGeer PL, McGeer EG (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 21:195–218
Mori K, Obara Y, Hirota M, Azumi Y, Kinugasa S, Inatomi S, Nakahata N (2008) Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biol Pharm Bull 31:1727–1732
Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T (2009) Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phyther Res 23:367–372. https://doi.org/10.1002/ptr.2634
Murphy MP, LeVine H (2010) Alzheimer’s disease and the amyloid-β peptide. J Alzheimers Dis 19:311–323. https://doi.org/10.3233/JAD-2010-1221
Nallathamby N, Phan CW, Seow SLS, Baskaran A, Lakshmanan H, Abd Malek SN, Sabaratnam V (2018) A status review of the bioactive activities of tiger milk mushroom Lignosus rhinocerotis (Cooke) Ryvarden. Front Pharmacol 8:998. https://doi.org/10.3389/fphar.2017.00998
Nishina A, Kimura H, Sekiguchi A, Fukumoto R, Nakajima S, Furukawa S (2006) Lysophosphatidylethanolamine in Grifola frondosa as a neurotrophic activator via activation of MAPK. J Lipid Res 47:1434–1443. https://doi.org/10.1194/jlr.M600045-JLR200
Ohta T, Kita T, Kobayashi N, Obara Y, Nakahata N, Ohizumi Y, Takaya Y, Oshima Y (1998) Scabronine A, a novel diterpenoid having potent inductive activity of the nerve growth factor synthesis, isolated from the mushroom, Sarcodon scabrosus. Tetrahedron Lett 39:6229–6232. https://doi.org/10.1016/S0040-4039(98)01282-9
Okuyama S, Lam NV, Hatakeyama T, Terashima T, Yamagata K, Yokogoshi H (2004) Mycoleptodonoides aitchisonii affects brain nerve growth factor concentration in newborn rats. Nutr Neurosci 7:341–349. https://doi.org/10.1080/10284150400020490
Park KJ, Lee SY, Kim HS, Yamazaki M, Chiba K, Ha H-C (2007) The neuroprotective and neurotrophic effects of Tremella fuciformis in PC12h cells. Mycobiology 35:11–15. https://doi.org/10.4489/MYCO.2007.35.1.011
Park HJ, Shim HS, Ahn YH, Kim KS, Park KJ, Choi WK, Ha HC, Il KJ, Kim TS, Yeo IH, Kim JS, Shim I (2012) Tremella fuciformis enhances the neurite outgrowth of PC12 cells and restores trimethyltin-induced impairment of memory in rats via activation of CREB transcription and cholinergic systems. Behav Brain Res 229:82–90. https://doi.org/10.1016/J.BBR.2011.11.017
Phan CW, David P, Naidu M, Wong KH, Sabaratnam V (2015) Therapeutic potential of culinary-medicinal mushrooms for the management of neurodegenerative diseases: diversity, metabolite, and mechanism. Crit Rev Biotechnol 35:355–368. https://doi.org/10.3109/07388551.2014.887649
Przedborski S, Vila M, Jackson Lewis V (2003) Neurodegeneration: what is it and where are we? J Clin Invest 111:3–10. https://doi.org/10.1172/JCI17522
Qi J, Ojika M, Sakagami Y (2000) Termitomycesphins A–D, novel neuritogenic cerebrosides from the edible chinese mushroom Termitomyces albuminosus. Tetrahedron 56:5835–5841. https://doi.org/10.1016/S0040-4020(00)00548-2
Qu Y, Sun K, Gao L, Sakagami Y, Kawagishi H, Ojika M, Qi J (2012) Termitomycesphins G and H, additional cerebrosides from the edible Chinese mushroom Termitomyces albuminosus. Biosci Biotechnol Biochem 76:791–793. https://doi.org/10.1271/bbb.110918
Quang DN, Hashimoto T, Nukada M, Yamamoto I, Tanaka M, Asakawa Y (2003) Curtisians E-H: four p-terphenyl derivatives from the inedible mushroom Paxillus curtisii. Phytochemistry 64:649–654
Sabaratnam V, Kah-Hui W, Naidu M, David PR (2013) Neuronal health – can culinary and medicinal mushrooms help? J Tradit Complement Med 3:62–68. https://doi.org/10.4103/2225-4110.106549
Seow SLS, Eik LF, Naidu M, David P, Wong KH, Sabaratnam V (2015) Lignosus rhinocerotis (Cooke) Ryvarden mimics the neuritogenic activity of nerve growth factor via MEK/ERK1/2 signaling pathway in PC-12 cells. Sci Rep 5:16349. https://doi.org/10.1038/srep16349
Shi XW, Liu L, Gao JM, Zhang AL (2011) Cyathane diterpenes from Chinese mushroom Sarcodon scabrosus and their neurite outgrowth-promoting activity. Eur J Med Chem 46:3112–3117. https://doi.org/10.1016/J.EJMECH.2011.04.006
Shibata H, Irie A, Morita Y (1998) New antibacterial diterpenoids from the Sarcodon scabrosus fungus. Biosci Biotechnol Biochem 62:2450–2452. https://doi.org/10.1271/bbb.62.2450
Skovronsky DM, Lee VMY, Trojanowski JQ (2006) Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol Mech Dis 1:151–170. https://doi.org/10.1146/annurev.pathol.1.110304.100113
Soytong K, Asue T (2012) Study on physiological and cultural requirements of Pleurotus giganteus. Int J Agric Technol 10:923–930
Sticht G, Käferstein H (2000) Detection of psilocin in body fluids. Forensic Sci Int 113:403–407. https://doi.org/10.1016/S0379-0738(00)00213-9
Teichert A, Schmidt J, Porzel A, Arnold N, Wessjohann L (2007) Brunneins A–C, β-carboline alkaloids from Cortinarius brunneus. J Nat Prod 70:1529–1531. https://doi.org/10.1021/np070259w
Trovato Salinaro A, Pennisi M, Di Paola R, Scuto M, Crupi R, Cambria MT, Ontario ML, Tomasello M, Uva M, Maiolino L, Calabrese EJ, Cuzzocrea S, Calabrese V (2018) Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms. Immun Ageing 15:8. https://doi.org/10.1186/s12979-017-0108-1
Trovato A, Siracusa R, Di Paola R, Scuto M, Fronte V, Koverech G, Luca M, Serra A, Toscano MA, Petralia A, Cuzzocrea S, Calabrese V (2016) Redox modulation of cellular stress response and lipoxin A4 expression by Coriolus versicolor in rat brain: relevance to Alzheimer’s disease pathogenesis. Neurotoxicology 53:350–358. https://doi.org/10.1016/J.NEURO.2015.09.012
Ueda K, Tsujimori M, Kodani S, Chiba A, Kubo M, Masuno K, Sekiya A, Nagai K, Kawagishi H (2008) An endoplasmic reticulum (ER) stress-suppressive compound and its analogues from the mushroom Hericium erinaceum. Bioorg Med Chem 16:9467–9470. https://doi.org/10.1016/J.BMC.2008.09.044
Wachtel Galor S, Yuen J, Buswell JA, Benzie IFF (2011) Ganoderma lucidum (Lingzhi or Reishi): a medicinal mushroom. Oxid Stress Dis 28:175–200
Wang Z, Luo D, Liang Z (2004) Structure of polysaccharides from the fruiting body of Hericium erinaceus Pers. Carbohydr Polym 57:241–247. https://doi.org/10.1016/J.CARBPOL.2004.04.018
Wang LC, Wang SE, Wang JJ, Tsai TY, Lin CH, Pan TM, Lee CL (2012) In vitro and in vivo comparisons of the effects of the fruiting body and mycelium of Antrodia camphorata against amyloid β-protein-induced neurotoxicity and memory impairment. Appl Microbiol Biotechnol 94:1505–1519. https://doi.org/10.1007/s00253-012-3941-3
Wasser S (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60:258–274. https://doi.org/10.1007/s00253-002-1076-7
Waters SP, Tian Y, Li YM, Danishefsky SJ (2005) Total synthesis of (−)-scabronine G, an inducer of neurotrophic factor production. J Am Chem Soc 127:13514–13515. https://doi.org/10.1021/ja055220x
Wender PA, Bi FC, Brodney MA, Gosselin F (2001) Asymmetric synthesis of the tricyclic core of NGF-inducing cyathane diterpenes via a transition-metal-catalyzed [5 + 2] cycloaddition. Org Lett 3:2105–2108
Yap YH, Tan N, Fung S, Aziz AA, Tan C, Ng S (2013) Nutrient composition, antioxidant properties, and anti-proliferative activity of Lignosus rhinocerus Cooke sclerotium. J Sci Food Agric 93:2945–2952. https://doi.org/10.1002/jsfa.6121
Yoon HM, Jang KJ, Han MS, Jeong JW, Kim GY, Lee JH, Choi YH (2013) Ganoderma lucidum ethanol extract inhibits the inflammatory response by suppressing the NF-κB and toll-like receptor pathways in lipopolysaccharide-stimulated BV2 microglial cells. Exp Ther Med 5:957–963. https://doi.org/10.3892/etm.2013.895
Yun BS, Lee IK, Kim JP, Yoo ID (2000) Leucomentin-5 and -6, two new leucomentin derivatives from the mushroom Paxillus panuoides. J Antibiot (Tokyo) 53:711–713
Zhang R, Xu S, Cai Y, Zhou M, Zuo X, Chan P (2011) Ganoderma lucidum protects dopaminergic neuron degeneration through inhibition of microglial activation. Evid Based Complement Alternat Med 2011:156810. https://doi.org/10.1093/ecam/nep075
Zhou Y, Qu Z, Zeng Y, Lin Y, Li Y, Chung P, Wong R, Hägg U (2012) Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus. Exp Toxicol Pathol 64:673–680. https://doi.org/10.1016/J.ETP.2010.12.011
Zinkand WC, Moore WC, Thompson C, Salama AI, Patel J (1992) Ibotenic acid mediates neurotoxicity and phosphoinositide hydrolysis by independent receptor mechanisms. Mol Chem Neuropathol 16:1–10. https://doi.org/10.1007/BF03159956
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Lee, W. et al. (2019). Role of Mushrooms in Neurodegenerative Diseases. In: Agrawal, D., Dhanasekaran, M. (eds) Medicinal Mushrooms. Springer, Singapore. https://doi.org/10.1007/978-981-13-6382-5_8
Download citation
DOI: https://doi.org/10.1007/978-981-13-6382-5_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-6381-8
Online ISBN: 978-981-13-6382-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)